{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:43:15Z","timestamp":1776508995294,"version":"3.51.2"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"crossref","award":["6\/9-7(266)\/KA\/2021-ECD-II"],"award-info":[{"award-number":["6\/9-7(266)\/KA\/2021-ECD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"DOI":"10.1007\/s12026-026-09775-1","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T08:52:43Z","timestamp":1776502363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epitope prediction and immunogenicity assessment of Leishmania donovani TryS protein as a potential vaccine candidate"],"prefix":"10.1007","volume":"74","author":[{"given":"Ehasanullah","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manash","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasoon","family":"Madhukar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikash Kumar","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"9775_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, Lindahl E. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1\u20132:19\u201325.","journal-title":"SoftwareX"},{"key":"9775_CR2","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"JVIDBCHMDPCJJJBM Alvar","year":"2012","unstructured":"Alvar JVIDBCHMDPCJJJBM. Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE. 2012;7:e35671.","journal-title":"PLoS ONE"},{"key":"9775_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1021\/ct900549r","volume":"6","author":"P Bjelkmar","year":"2010","unstructured":"Bjelkmar P, Larsson P, Cuendet MA, Hess B, Lindahl E. Implementation of the CHARMM Force FieLd in GROMACS: Analysis of Protein Stability Effects from Correction Maps, Virtual Interaction Sites, and Water Models. J Chem Theory Comput. 2010;6:459\u201366.","journal-title":"J Chem Theory Comput"},{"key":"9775_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.freeradbiomed.2024.10.257","volume":"225","author":"K Bora","year":"2024","unstructured":"Bora K, Sarma M, Kanaujia SP, Dubey VK. Development of novel dual-target drugs against visceral leishmaniasis and combinational study with miltefosine. Free Radic Biol Med. 2024;225:275\u201385.","journal-title":"Free Radic Biol Med"},{"key":"9775_CR5","doi-asserted-by":"publisher","first-page":"100971","DOI":"10.1016\/j.lanepe.2024.100971","volume":"43","author":"BM Carvalho","year":"2024","unstructured":"Carvalho BM, Maia C, Courtenay O, Llabr\u00e9s-Brustenga A, Lotto Batista M, Moirano G, van Daalen KR, Semenza JC, Lowe R. A climatic suitability indicator to support Leishmania infantum surveillance in Europe: a modelling study. Lancet Reg Health - Europe. 2024;43:100971.","journal-title":"Lancet Reg Health - Europe"},{"key":"9775_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40249-020-00713-3","volume":"9","author":"HZ Chen","year":"2020","unstructured":"Chen HZ, Tang LL, Yu XL, Zhou J, Chang YF, Wu X. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2. Infect Dis poverty. 2020;9:88.","journal-title":"Infect Dis poverty"},{"key":"9775_CR7","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-025-02264-1","volume":"10","author":"R Chen","year":"2025","unstructured":"Chen R, Zou J, Chen J, Zhong X, Kang R, Tang D. Pattern recognition receptors: function, regulation and therapeutic potential. Signal Transduct Target Therapy. 2025;10:216.","journal-title":"Signal Transduct Target Therapy"},{"key":"9775_CR8","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1038\/s41598-024-52223-z","volume":"14","author":"A Choudhury","year":"2024","unstructured":"Choudhury A, Kumar P, Nafidi H-A, Almaary KS, Wondmie GF, Kumar A, Bourhia M. Immunoinformatics approaches in developing a novel multi-epitope chimeric vaccine protective against Saprolegnia parasitica. Sci Rep. 2024;14:2260.","journal-title":"Sci Rep"},{"key":"9775_CR9","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1038\/cti.2015.6","volume":"4","author":"RN Coler","year":"2015","unstructured":"Coler RN, Duthie MS, Hofmeyer KA, Guderian J, Jayashankar L, Vergara J, Rolf T, Misquith A, Laurance JD, Raman VS, Bailor HR, Cauwelaert ND, Reed SJ, Vallur A, Favila M, Orr MT, Ashman J, Ghosh P, Mondal D, Reed SG. From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3\u2009+\u2009GLA-SE. Clin translational Immunol. 2015;4:e35.","journal-title":"Clin translational Immunol"},{"key":"9775_CR10","doi-asserted-by":"publisher","unstructured":"Cordeiro-Da-Silva A, Cecilio P, Oliveira L. Vaccines for human leishmaniasis: where do we stand and what is still missing? In: Afrin F, Hemeg H, editors. Leishmaniases as re-emerging diseases. Rijeka: IntechOpen; 2018. https:\/\/doi.org\/10.5772\/intechopen.75000.","DOI":"10.5772\/intechopen.75000"},{"key":"9775_CR11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","volume":"29","author":"S Crotty","year":"2011","unstructured":"Crotty S. Follicular Helper CD4 T Cells (TFH). Annu Rev Immunol. 2011;29:621\u201363.","journal-title":"Annu Rev Immunol"},{"key":"9775_CR12","doi-asserted-by":"crossref","unstructured":"de Franca MNF, Rodrigues LS, Barreto AS, da Cruz GS, Arag\u00e3o-Santos JC, da Silva AM, de Jesus AR, Palatnik-de-Sousa CB, de Almeida RP, Corr\u00eaa CB. CD4\u2009+\u2009Th1 and Th17 responses and multifunctional CD8 T lymphocytes associated with cure or disease worsening in human visceral leishmaniasis. Front Immunol. 2024;1277557:15\u20132024.","DOI":"10.3389\/fimmu.2024.1277557"},{"key":"9775_CR13","doi-asserted-by":"publisher","unstructured":"Duan T, Du Y, Xing C, Wang HY, Wang R-F. Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol. 2022;13\u20132022. https:\/\/doi.org\/10.3389\/fimmu.2022.812774.","DOI":"10.3389\/fimmu.2022.812774"},{"key":"9775_CR14","doi-asserted-by":"crossref","unstructured":"Gasteiger E, Hoogland C, Gattiker A, Duvaud Se, Wilkins MR, Appel RD, Bairoch A. Protein identification and analysis tools on the ExPASy server. The proteomics protocols handbook: 571\u2013607. 2005.","DOI":"10.1385\/1-59259-890-0:571"},{"key":"9775_CR15","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1093\/bioinformatics\/btx345","volume":"33","author":"M Hebditch","year":"2017","unstructured":"Hebditch M, Carballo-Amador MA, Charonis S, Curtis R, Warwicker J. Protein\u2013Sol: a web tool for predicting protein solubility from sequence. Bioinformatics. 2017;33:3098\u2013100.","journal-title":"Bioinformatics"},{"key":"9775_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv LB. IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 2018;18:545\u201358.","journal-title":"Nat Rev Immunol"},{"key":"9775_CR17","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","volume":"45","author":"MC Jespersen","year":"2017","unstructured":"Jespersen MC, Peters B, Nielsen M, Marcatili P. BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res. 2017;45:W24\u20139.","journal-title":"Nucleic Acids Res"},{"key":"9775_CR18","doi-asserted-by":"publisher","first-page":"1269774","DOI":"10.3389\/fimmu.2023.1269774","volume":"14","author":"R Jyotisha, Qureshi","year":"2023","unstructured":"Jyotisha, Qureshi R, Qureshi IA. Development of a multi-epitope vaccine candidate for leishmanial parasites applying immunoinformatics and in vitro approaches. Front Immunol. 2023;14:1269774.","journal-title":"Front Immunol"},{"key":"9775_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4103\/0974-777X.62881","volume":"2","author":"L Kedzierski","year":"2010","unstructured":"Kedzierski L. Leishmaniasis Vaccine: Where are We Today? J global Infect Dis. 2010;2:177\u201385.","journal-title":"J global Infect Dis"},{"key":"9775_CR20","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3389\/fimmu.2020.01351","volume":"11","author":"MP Kostinov","year":"2020","unstructured":"Kostinov MP, Akhmatova NK, Khromova EA, Kostinova AM. Cytokine Profile in Human Peripheral Blood Mononuclear Leukocytes Exposed to Immunoadjuvant and Adjuvant-Free Vaccines Against Influenza. Front Immunol. 2020;11:1351.","journal-title":"Front Immunol"},{"key":"9775_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41541-020-00224-0","volume":"5","author":"DP Lage","year":"2020","unstructured":"Lage DP, Ribeiro PAF, Dias DS, Mendon\u00e7a DVC, Ramos FF, Carvalho LM, de Oliveira D, Steiner BT, Martins VT, Perin L, Machado AS, Santos TTO, Tavares GSV, Oliveira-da-Silva JA, Oliveira JS, Roatt BM, Machado-de-\u00c1vila RA, Teixeira AL, Humbert MV, Coelho EAF, Christodoulides M. A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection. npj Vaccines. 2020;5:75.","journal-title":"npj Vaccines"},{"key":"9775_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/1471-2105-8-424","volume":"8","author":"MV Larsen","year":"2007","unstructured":"Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics. 2007;8:424.","journal-title":"BMC Bioinformatics"},{"key":"9775_CR23","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3389\/fimmu.2017.01175","volume":"8","author":"D Maeda","year":"2017","unstructured":"Maeda D, Batista MT, Pereira LR, de Jesus Cintra M, Amorim JH, Mathias-Santos C, Pereira SA, Boscardin SB, Silva SDR, Faquim-Mauro EL, Silveira VB, Oliveira DBL, Johnston SA, Ferreira LCS, Rodrigues JF. Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein. Front Immunol. 2017;8:1175.","journal-title":"Front Immunol"},{"key":"9775_CR24","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/bioinformatics\/btp386","volume":"25","author":"CN Magnan","year":"2009","unstructured":"Magnan CN, Randall A. SOLpro: accurate sequence-based prediction of protein solubility. Bioinformatics. 2009;25:2200\u20137. BaLdi P.","journal-title":"Bioinformatics"},{"key":"9775_CR25","doi-asserted-by":"publisher","first-page":"e1011502","DOI":"10.1371\/journal.ppat.1011502","volume":"20","author":"AT Martin","year":"2024","unstructured":"Martin AT, Giri S, Safronova A, Eliseeva SI, Kwok SF, Yarovinsky F. Parasite-induced IFN-\u03b3 regulates host defense via CD115 and mTOR-dependent mechanism of tissue-resident macrophage death. PLoS Pathog. 2024;20:e1011502.","journal-title":"PLoS Pathog"},{"key":"9775_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s13071-015-0964-5","volume":"8","author":"VT Martins","year":"2015","unstructured":"Martins VT, Duarte MC, Ch\u00e1vez-Fumagalli MA, Menezes-Souza D, Coelho CSP, de Magalh\u00e3es-Soares DF, Fernandes AP, Soto M, Tavares CAP, Coelho EAF. A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis. Parasites Vectors. 2015;8:363.","journal-title":"Parasites Vectors"},{"key":"9775_CR27","doi-asserted-by":"publisher","first-page":"6759","DOI":"10.1016\/j.vaccine.2008.09.085","volume":"26","author":"S Noazin","year":"2008","unstructured":"Noazin S, Modabber F, Khamesipour A, Smith PG, Moulton LH, Nasseri K, Sharifi I, Khalil EA, Bernal IDV, Antunes CM. First generation leishmaniasis vaccines: a review of fieLd efficacy trials. Vaccine. 2008;26:6759\u201367.","journal-title":"Vaccine"},{"key":"9775_CR28","doi-asserted-by":"publisher","unstructured":"Nyl\u00e9n S, Kumar R. Immunobiology of visceral leishmaniasis. Front Immunol. 2012;3:251. https:\/\/doi.org\/10.3389\/fimmu.2012.00251.","DOI":"10.3389\/fimmu.2012.00251"},{"key":"9775_CR29","doi-asserted-by":"publisher","first-page":"e0005527","DOI":"10.1371\/journal.pntd.0005527","volume":"11","author":"M Osman","year":"2017","unstructured":"Osman M, Mistry A, Keding A, Gabe R, Cook E, Forrester S, Wiggins R, Di Marco S, Colloca S, Siani L, Cortese R, Smith DF, Aebischer T, Kaye PM, Lacey CJ. A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH. PLoS Negl Trop Dis. 2017;11:e0005527.","journal-title":"PLoS Negl Trop Dis"},{"key":"9775_CR30","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.drudis.2020.03.006","volume":"25","author":"S Parvizpour","year":"2020","unstructured":"Parvizpour S, Pourseif MM, Razmara J, Rafi MA, Omidi Y. Epitope-based vaccine design: a comprehensive overview of bioinformatics approaches. Drug Discovery Today. 2020;25:1034\u201342.","journal-title":"Drug Discovery Today"},{"key":"9775_CR31","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/eji.201242428","volume":"42","author":"J Paul","year":"2012","unstructured":"Paul J, Karmakar S, De T. TLR-mediated distinct IFN-\u03b3\/IL-10 pattern induces protective immunity against murine visceral leishmaniasis. Eur J Immunol. 2012;42:2087\u201399.","journal-title":"Eur J Immunol"},{"key":"9775_CR32","doi-asserted-by":"publisher","first-page":"e0006052","DOI":"10.1371\/journal.pntd.0006052","volume":"11","author":"A Ponte-Sucre","year":"2017","unstructured":"Ponte-Sucre A, Gamarro F, Dujardin JC, Barrett MP, L\u00f3pez-V\u00e9lez R, Garc\u00eda-Hern\u00e1ndez R, Pountain AW, Mwenechanya R, Papadopoulou B. Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLoS Negl Trop Dis. 2017;11:e0006052.","journal-title":"PLoS Negl Trop Dis"},{"key":"9775_CR33","doi-asserted-by":"publisher","first-page":"14048","DOI":"10.1038\/s41598-024-64383-z","volume":"14","author":"A Pumchan","year":"2024","unstructured":"Pumchan A, Proespraiwong P, Sawatdichaikul O, Phurahong T, Hirono I, Unajak S. Computational design of novel chimeric multiepitope vaccine against bacterial and viral disease in tilapia (Oreochromis sp). Sci Rep. 2024;14:14048.","journal-title":"Sci Rep"},{"key":"9775_CR34","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.tig.2020.01.008","volume":"36","author":"J Radwan","year":"2020","unstructured":"Radwan J, Babik W, Kaufman J, Lenz TL, Winternitz J. Advances in the evolutionary understanding of MHC polymorphism. Trends Genet. 2020;36:298\u2013311.","journal-title":"Trends Genet"},{"key":"9775_CR35","doi-asserted-by":"publisher","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","volume":"5","author":"N Rapin","year":"2010","unstructured":"Rapin N, Lund O, Bernaschi M, Castiglione F. Computational Immunology Meets Bioinformatics: The Use of Prediction Tools for Molecular Binding in the Simulation of the Immune System. PLoS ONE. 2010;5:e9862.","journal-title":"PLoS ONE"},{"key":"9775_CR36","doi-asserted-by":"publisher","first-page":"399","DOI":"10.20506\/rst.27.2.1803","volume":"27","author":"P Ready","year":"2008","unstructured":"Ready P. Leishmaniasis emergence and climate change. Rev Sci Tech. 2008;27:399\u2013412.","journal-title":"Rev Sci Tech"},{"key":"9775_CR37","doi-asserted-by":"publisher","first-page":"e00248","DOI":"10.1128\/iai.00248-22","volume":"90","author":"A Saha","year":"2022","unstructured":"Saha A, Roy S, Ukil A. Cytokines and Signaling Networks Regulating Disease Outcomes in Leishmaniasis. Infect Immun. 2022a;90:e00248\u201300222.","journal-title":"Infect Immun"},{"key":"9775_CR38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/prot.21078","volume":"65","author":"S Saha","year":"2006","unstructured":"Saha S, Raghava GP. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins. 2006;65:40\u20138.","journal-title":"Proteins"},{"key":"9775_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12859-022-04816-6","volume":"23","author":"S Saha","year":"2022","unstructured":"Saha S, Vashishtha S, Kundu B, Ghosh M. In-silico design of an immunoinformatics based multi-epitope vaccine against Leishmania donovani. BMC Bioinformatics. 2022b;23:319.","journal-title":"BMC Bioinformatics"},{"key":"9775_CR40","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1515\/BC.2011.222","volume":"392","author":"P Saudagar","year":"2011","unstructured":"Saudagar P, Dubey VK. Cloning, expression, characterization and inhibition studies on trypanothione synthetase, a drug target enzyme, from Leishmania donovani. Biol Chem. 2011;392:1113\u201322.","journal-title":"Biol Chem"},{"key":"9775_CR41","unstructured":"Saurabh JSM. Junerlyn FVA, Ana NM-E, Samantha V, Supriya W, Mona O, Aya Y, Abate B, Jos\u00e9 AR-P. Global leishmaniasis surveillance updates 2023: 3 years of the NTD road map. 2024"},{"key":"9775_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11756-021-00934-3","volume":"77","author":"M Shams","year":"2022","unstructured":"Shams M, Nourmohammadi H, Majidiani H, Shariatzadeh SA, Asghari A, Fatollahzadeh M, Irannejad H. Engineering a multi-epitope vaccine candidate against Leishmania infantum using comprehensive Immunoinformatics methods. Biologia. 2022;77:277\u201389.","journal-title":"Biologia"},{"key":"9775_CR43","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1186\/s12879-025-10768-y","volume":"25","author":"NA Siddiqui","year":"2025","unstructured":"Siddiqui NA, Pandey DK, Singh AK, Sinha SK, Ansari MZ, Kumar R, Pal B, Das VNR, Adhikary R, Jain S, Pandey K. A clinico-epidemiological study, assessing possible predictors of mortality and health-related quality of life for people living with visceral leishmaniasis \u2013 human immune virus (VL-HIV) co-infection in a high burden kala-azar endemic state of India: a descriptive cross-sectional study. BMC Infect Dis. 2025;25:887.","journal-title":"BMC Infect Dis"},{"key":"9775_CR44","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1103\/PhysRevLett.79.4493","volume":"79","author":"S Succi","year":"1997","unstructured":"Succi S, Castiglione F, Bernaschi M. Collective Dynamics in the Immune System Response. Phys Rev Lett. 1997;79:4493\u20136.","journal-title":"Phys Rev Lett"},{"key":"9775_CR45","doi-asserted-by":"publisher","first-page":"104692","DOI":"10.1016\/j.arabjc.2023.104692","volume":"16","author":"J Suhail Wadi","year":"2023","unstructured":"Suhail Wadi J, Al-Duhaidahawi D, salam abdullah S, Jabir M, Najim MAA, Farhan Jawad S, Hamzah SS, Abdul Qais F. Exploring the interaction between 3-D structure of TLR 9 and prostaglandin analogues. Arab J Chem. 2023;16:104692.","journal-title":"Arab J Chem"},{"key":"9775_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/14787210.2024.2438627","volume":"23","author":"S Sundar","year":"2025","unstructured":"Sundar S, Madhukar P, Kumar R. Anti-leishmanial therapies: overcoming current challenges with emerging therapies. Expert Rev Anti-infective Therapy. 2025;23:159\u201380.","journal-title":"Expert Rev Anti-infective Therapy"},{"key":"9775_CR47","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s00704-023-04726-4","volume":"155","author":"AJ Tr\u00e1jer","year":"2024","unstructured":"Tr\u00e1jer AJ, Grmasha RA. The potential effects of climate change on the climatic suitability patterns of the Western Asian vectors and parasites of cutaneous leishmaniasis in the mid- and late twenty-first century. Theoret Appl Climatol. 2024;155:1897\u2013914.","journal-title":"Theoret Appl Climatol"},{"key":"9775_CR48","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26:1701\u201318.","journal-title":"J Comput Chem"},{"key":"9775_CR49","unstructured":"WHO. Leishmaniasis. WorLd Health Organization; 2023."},{"key":"9775_CR50","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/20477724.2020.1842976","volume":"114","author":"S Yadav","year":"2020","unstructured":"Yadav S, Prakash J, Shukla H, Das KC, Tripathi T, Dubey VK. Design of a multi-epitope subunit vaccine for immune-protection against Leishmania parasite. Pathogens global health. 2020;114:471\u201381.","journal-title":"Pathogens global health"},{"key":"9775_CR51","doi-asserted-by":"publisher","first-page":"e0246150","DOI":"10.1371\/journal.pone.0246150","volume":"16","author":"C-W Yang","year":"2021","unstructured":"Yang C-W, Shi Z-L. Uncovering potential host proteins and pathways that may interact with eukaryotic short linear motifs in viral proteins of MERS, SARS and SARS2 coronaviruses that infect humans. PLoS ONE. 2021;16:e0246150.","journal-title":"PLoS ONE"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09775-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09775-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09775-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:02:24Z","timestamp":1776506544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09775-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9775"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09775-1","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}